Healthcare provider profile · identity verified

Jeffrey D Thatcher, MD

Internal Medicine · TELFORD, PA · NPI 1871547216

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	246	58
Atorvastatin Calcium	Atorvastatin Calcium	246	65
Levothyroxine Sodium	Levothyroxine Sodium	209	41
Lorazepam	Lorazepam	188	39
Famotidine	Famotidine	178	43
Escitalopram Oxalate	Escitalopram Oxalate	161	35
Simvastatin	Simvastatin	145	37
Furosemide	Furosemide	143	35
Lisinopril	Lisinopril	141	37
Omeprazole	Omeprazole	131	40
Losartan Potassium	Losartan Potassium	112	24
Pantoprazole Sodium	Pantoprazole Sodium	111	27
Metformin Hcl	Metformin Hcl	110	26
Gabapentin	Gabapentin	101	20
Metoprolol Succinate	Metoprolol Succinate	100	24
Tamsulosin Hcl	Tamsulosin Hcl	81	15
Sertraline Hcl	Sertraline Hcl	79	20
Hydrochlorothiazide	Hydrochlorothiazide	75	21
Prednisone	Prednisone	59	36
Glimepiride	Glimepiride	57	13
Pravastatin Sodium	Pravastatin Sodium	57	11
Tramadol Hcl	Tramadol Hcl	57	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	15
Warfarin Sodium	Warfarin Sodium	53	suppressed
Citalopram Hbr	Citalopram Hydrobromide	51	13
Duloxetine Hcl	Duloxetine Hcl	47	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	41	12
Metoprolol Tartrate	Metoprolol Tartrate	40	suppressed
Allopurinol	Allopurinol	39	suppressed
Mirtazapine	Mirtazapine	39	13
Fluticasone Propionate	Fluticasone Propionate	32	15
Montelukast Sodium	Montelukast Sodium	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Azithromycin	Azithromycin	29	28
Diclofenac Sodium	Diclofenac Sodium	28	14
Carvedilol	Carvedilol	27	suppressed
Eliquis	Apixaban	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	11
Cefuroxime	Cefuroxime Axetil	26	24
Lovastatin	Lovastatin	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	12
Finasteride	Finasteride	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	14
Atenolol	Atenolol	17	suppressed
Glipizide	Glipizide	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Betamethasone Valerate	Betamethasone Valerate	16	12
Cephalexin	Cephalexin	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	11
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Trazodone Hcl	Trazodone Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Jardiance	Empagliflozin	14	suppressed
Methylprednisolone	Methylprednisolone	14	11
Benazepril Hcl	Benazepril Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error